Sam Hawley: Okay, well, let's come a bit more to the risks in a moment
Their effectiveness in promoting significant weight loss, combined with cardiovascular benefits and a favorable safety profile, makes them valuable options for many patients struggling with obesity
Studies show it can greatly improve symptoms of neuropathy
Our research found it affected 5.4% of semaglutide users and 9.6% of tirzepatide users at 12 months
Body composition and metabolic health assessments provide insight into factors such as muscle mass, fat distribution, insulin sensitivity, and overall metabolic efficiency
It may be particularly helpful for people who: Have type 2 diabetes with excess weight or insulin resistance Have inadequate control on metformin or other oral therapies Want to minimise hypoglycaemia risk Wish to delay or reduce insulin requirements As with all diabetes therapies, Mounjaro works best when combined with sustainable changes in eating patterns, activity, sleep, and long-term support themes we explore in depth across our education programs and webinars
